Filtered By:
Condition: Aortic Stenosis
Procedure: Heart Valve Surgery

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 839 results found since Jan 2013.

Laparoscopic adrenalectomy of pheochromocytoma following management of severe aortic stenosis with transcatheter aortic valve replacement under monitored anesthesia care sedation: a case report
Management of a patient with an active pheochromocytoma and severe aortic stenosis remains controversial. Adrenalectomy for a pheochromocytoma poses a high risk for stroke, hypertensive emergency, and mortalit...
Source: BMC Anesthesiology - January 11, 2023 Category: Anesthesiology Authors: Leon Yang, Lauren Hennis, Kevin Patel and Michael A. Saccocci Tags: Case report Source Type: research

Cost-Effectiveness of SAPIEN  3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk
ConclusionsTAVI with SAPIEN  3 appears to be a clinically meaningful, cost-effective treatment option over SAVR for patients with severe symptomatic aortic stenosis and low risk for surgical mortality in Germany.Clinical Trial Registration Numberwww.clinicaltrials.gov identifier: NCT02675114.
Source: Advances in Therapy - January 9, 2023 Category: Drugs & Pharmacology Source Type: research

Outcomes of Root Enlargement Versus Root Replacement for Aortic Stenosis
CONCLUSIONS: ARE and stentless xenograft ARR for aortic stenosis were associated with comparable postoperative complications, aortic valve reinterventions, freedom from readmission, and 5-year survival.PMID:36584836 | DOI:10.1016/j.athoracsur.2022.12.027
Source: The Annals of Thoracic Surgery - December 30, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Sarah Yousef Derek Serna-Gallegos James A Brown Takuya Ogami Yisi Wang Floyd W Thoma Danny Chu Johannes Bonatti David Kaczorowski Pyongsoo Yoon Ibrahim Sultan Source Type: research

Short- and Mid-Term Outcomes of Complex and High-Risk Versus Standard Percutaneous Coronary Interventions in Patients Undergoing Transcatheter Aortic Valve Replacement
J Invasive Cardiol. 2022 Dec 15:JIC20221215-2. Online ahead of print.ABSTRACTThe prevalence of coronary artery disease (CAD) in patients undergoing TAVR varies and is associated with increased morbidity and mortality. We evaluated the outcomes of complex and high-risk percutaneous coronary interventions (CHIP-PCIs) and TAVR compared with standard PCI and TAVR. Between January 2014 and March 2021, a total of 276 consecutive patients with severe aortic stenosis (AS) who underwent TAVR and PCI at 3 centers within Northwell Health were retrospectively reviewed. CHIP-PCI was defined as PCI with one of the following: left ventri...
Source: The Journal of Invasive Cardiology - December 16, 2022 Category: Cardiology Authors: Arber Kodra Craig Basman Luigi Pirelli Denny Wang Hamfreth Rahming Richard Chaudhary Shangyi Liu Ahmad Mustafa Bruce Rutkin Gregory Maniatis Robert Kalimi Sean Wilson Pey-Jen Yu Michael Kim Varinder Singh Perwaiz Meraj Rajiv Jauhar Ruben Kandov Puneet Gan Source Type: research

Transcatheter heart valve selection in patients with low ejection fraction and aortic stenosis
ConclusionThe choice of THV in patients with severe AS and systolic dysfunction must be weighed on a case-by-case basis.
Source: Journal of Cardiac Surgery - November 15, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Ahmad Mustafa, Chad Kliger, Luigi Pirelli, Arber Kodra, Denny Wang, Priyanka Singh, Paley Arnone, Apurva Patel, Shangyi Liu, Efstathia Mihelis, Elana Koss, Sean Wilson, Gregory Maniatis, Mohammed Imam, Puneet Gandotra, Robert Kalimi, Azhar Tags: ORIGINAL ARTICLE Source Type: research

Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials
Transcatheter aortic valve replacement (TAVR) has become a mainstay treatment option for most patients with severe symptomatic aortic stenosis. Although the majority of TAVR-related complications have decreased overtime, stroke rates remained relatively unchanged.1,2 Hence, numerous efforts have been devoted to developing effective strategies to mitigate the risk of post-TAVR strokes. We performed an updated meta-analysis to assess the efficacy and safety of cerebral embolic protection (CEP) during TAVR.
Source: The American Journal of Cardiology - November 14, 2022 Category: Cardiology Authors: Abdullah Al-Abcha, Yehia Saleh, Muhannad Abbasi, Edward El-Am, Mohamad Alkhouli Source Type: research

Long-term changes in coronary physiology after aortic valve replacement
Conclusions: CFR in the LAD increased significantly at follow-up although global hyperaemic flow and minimal microvascular resistance remained unchanged. Thus, a decrease in resting flow was the cause of CFR improvement. CFR improvement was associated with reduction in LVSW.PMID:36239118 | DOI:10.4244/EIJ-D-22-00621
Source: EuroIntervention - October 14, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Muhammad Sabbah Niels T Olsen Lene Holmvang Hans-Henrik Tilsted Frants Pedersen Francis Richard Joshi Rikke S ørensen Reza Jabbari Ketina Arslani Lars Sondergaard Thomas Engstr øm Jacob Thomsen L ønborg Source Type: research

Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long ‐term prognostic impact
ConclusionsIn severe AS patients, lower MAP reflects lower systemic vascular resistance and valvulo-arterial impedance, which may help to preserve stroke volume and filling pressures despite reduced left ventricular performance, and lower MAP is a predictor of higher long-term post-AVR mortality.
Source: ESC Heart Failure - October 7, 2022 Category: Cardiology Authors: Micha T. Maeder, Hans Rickli, Lukas Weber, Daniel Weilenmann, Peter Ammann, Lucas Joerg, Philipp K. Haager, Johannes Rigger, Joannis Chronis, Roman Brenner Tags: Original Article Source Type: research

Cerebral Embolic Protection Does Not Prevent Stroke in TAVR
FRIDAY, Sept. 30, 2022 -- The use of cerebral embolic protection (CEP) does not have a significant impact on the incidence of periprocedural stroke among patients with aortic stenosis undergoing transfemoral transcatheter aortic-valve replacement...
Source: Drugs.com - Pharma News - September 30, 2022 Category: Pharmaceuticals Source Type: news

Investigation on Imaging Features and Clinical Significance of Cardiac CT in Comprehensive Evaluation of Aortic Valve and Root before Percutaneous Aortic Valve Replacement
This study retrospectively includes patients with severe aortic stenosis who underwent TAVR with routine computed tomography. Based on CT images, the determination and grouping of bicuspid aortic valve and tricuspid aortic valve were completed. Thirteen cross-sectional levels of the aorta-iliac-femoral vascular access were completed. The results showed that 3 people had stroke (17.6%) and 5 people had myocardial infarction (29.4%) during the follow-up period. Atrial fibrillation occurred in 5 patients (29.4%), permanent pacemaker implantation was performed in 1 patient (5.9%), and acute kidney injury occurred in 7 patients...
Source: Biomed Res - September 30, 2022 Category: Research Authors: Xiong Tan Juan Peng Source Type: research